Erika Finanger

2.3k total citations
26 papers, 682 citations indexed

About

Erika Finanger is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Erika Finanger has authored 26 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Erika Finanger's work include Muscle Physiology and Disorders (20 papers), Muscle activation and electromyography studies (5 papers) and Genetic Neurodegenerative Diseases (5 papers). Erika Finanger is often cited by papers focused on Muscle Physiology and Disorders (20 papers), Muscle activation and electromyography studies (5 papers) and Genetic Neurodegenerative Diseases (5 papers). Erika Finanger collaborates with scholars based in United States, Italy and Canada. Erika Finanger's co-authors include Krista Vandenborne, Glenn A. Walter, William D. Rooney, Sean C. Forbes, Barry S. Russman, Gihan Tennekoon, H. Lee Sweeney, Rebecca J. Willcocks, Claudia Senesac and Donovan J. Lott and has published in prestigious journals such as PLoS ONE, Neurology and Annals of Neurology.

In The Last Decade

Erika Finanger

25 papers receiving 678 citations

Peers

Erika Finanger

CCM

CMN

PHYSI

J.C. van den Bergen Netherlands

Rebecca J. Willcocks United States

V. Decostre France

Flaviana Bianco Italy

Roula Al‐Dahhak United States

Marie‐Louise Sveen Denmark

Jasjit Deol United States

Julia R. Dahlqvist Denmark

Maha Mahmoud Tunisia

Tina Duong United States

J.C. van den Bergen Netherlands

Erika Finanger

507 ×0.9

105 ×0.5

132 ×0.8

CCM

116 ×0.8

CMN

119 ×1.0

PHYSI

Citations per year, relative to Erika Finanger Erika Finanger (= 1×) peers J.C. van den Bergen

Countries citing papers authored by Erika Finanger

Since Specialization

Citations

This map shows the geographic impact of Erika Finanger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Finanger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Finanger more than expected).

Fields of papers citing papers by Erika Finanger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Finanger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Finanger. The network helps show where Erika Finanger may publish in the future.

Co-authorship network of co-authors of Erika Finanger

This figure shows the co-authorship network connecting the top 25 collaborators of Erika Finanger. A scholar is included among the top collaborators of Erika Finanger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika Finanger. Erika Finanger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Willcocks, Rebecca J., Michael J. Daniels, Sean C. Forbes, et al.. (2023). Clinical importance of changes in magnetic resonance biomarkers for Duchenne muscular dystrophy. Annals of Clinical and Translational Neurology. 11(1). 67–78. 3 indexed citations

Forbes, Sean C., Rebecca J. Willcocks, William Triplett, et al.. (2020). Upper and Lower Extremities in Duchenne Muscular Dystrophy Evaluated with Quantitative MRI and Proton MR Spectroscopy in a Multicenter Cohort. Radiology. 295(3). 616–625. 27 indexed citations

Willcocks, Rebecca J., William Triplett, Sean C. Forbes, et al.. (2020). MR biomarkers predict clinical function in Duchenne muscular dystrophy. Neurology. 94(9). e897–e909. 59 indexed citations

Lott, Donovan J., Tanja Taivassalo, Claudia Senesac, et al.. (2020). Walking activity in a large cohort of boys with Duchenne muscular dystrophy. Muscle & Nerve. 63(2). 192–198. 15 indexed citations

Finkel, Richard S., Krista Vandenborne, H. Lee Sweeney, et al.. (2019). Edasalonexent, an NF-kB Inhibitor, Slows Longer-Term Disease Progression on Multiple Functional and MRI Assessments Compared to Control Period in 4 to 7-Year Old Patients with Duchenne Muscular Dystrophy (S51.006). Neurology. 92(15_supplement). 2 indexed citations

Finkel, Richard S., Krista Vandenborne, H. Lee Sweeney, et al.. (2019). O.42Treatment of young boys with Duchenne muscular dystrophy with the NF-κB inhibitor edasalonexent showed a slowing of disease progression as assessed by MRI and functional measures. Neuromuscular Disorders. 29. S208–S208. 2 indexed citations

Gale, Michael J., Jenny L. Wilson, David M. Koeller, et al.. (2018). Longitudinal ophthalmic findings in a child with Helsmoortel-Van der Aa Syndrome. American Journal of Ophthalmology Case Reports. 10. 244–248. 6 indexed citations

Willcocks, Rebecca J., Erika Finanger, Michael J. Daniels, et al.. (2018). Skeletal muscle magnetic resonance biomarkers correlate with function and sentinel events in Duchenne muscular dystrophy. PLoS ONE. 13(3). e0194283–e0194283. 51 indexed citations

Finanger, Erika, Krista Vandenborne, Richard S. Finkel, et al.. (2018). Phase 1 Study of Edasalonexent (CAT-1004), an Oral NF-κB Inhibitor, in Pediatric Patients with Duchenne Muscular Dystrophy. Journal of Neuromuscular Diseases. 6(1). 43–54. 30 indexed citations

10.

Finkel, Richard S., Krista Vandenborne, H. Lee Sweeney, et al.. (2018). MoveDMD®: Positive Effects of Edasalonexent, an NF-κB Inhibitor, in 4 to 7-Year Old Patients with Duchenne Muscular Dystrophy in Phase 2 Study with an Open-Label Extension (S29.006). Neurology. 90(15_supplement). 1 indexed citations

11.

Willcocks, Rebecca J., Donovan J. Lott, Ann T. Harrington, et al.. (2018). Longitudinal timed function tests in Duchenne muscular dystrophy: ImagingDMD cohort natural history. Muscle & Nerve. 58(5). 631–638. 46 indexed citations

12.

Donovan, Joanne M., Krista Vandenborne, Gihan Tennekoon, et al.. (2017). Move DMD Results: Effects of Edasalonexent, an NF-kB Inhibitor, in 4 to 7 Year Old Patients with Duchenne Muscular Dystrophy (P3.210). Neurology. 88(16_supplement). 1 indexed citations

13.

Willcocks, Rebecca J., William D. Rooney, William Triplett, et al.. (2016). Multicenter prospective longitudinal study of magnetic resonance biomarkers in a large duchenne muscular dystrophy cohort. Annals of Neurology. 79(4). 535–547. 120 indexed citations

14.

Finanger, Erika, Krista Vandenborne, Richard S. Finkel, et al.. (2016). CAT-1004, an oral agent targeting NF-kB: MoveDMD trial results in Duchenne muscular dystrophy (DMD). Neuromuscular Disorders. 26. S157–S157. 1 indexed citations

15.

Forbes, Sean C., Rebecca J. Willcocks, William Triplett, et al.. (2014). Magnetic Resonance Imaging and Spectroscopy Assessment of Lower Extremity Skeletal Muscles in Boys with Duchenne Muscular Dystrophy: A Multicenter Cross Sectional Study. PLoS ONE. 9(9). e106435–e106435. 87 indexed citations

16.

Arpan, Ishu, Rebecca J. Willcocks, Sean C. Forbes, et al.. (2014). Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS. Neurology. 83(11). 974–980. 116 indexed citations

17.

Kishnani, Priya S., Mark A. Tarnopolsky, Mark Roberts, et al.. (2013). A phase 2a study to investigate drug–drug interactions between escalating doses of AT2220 (duvoglustat hydrochloride) and acid alfa-glucosidase in subjects with Pompe disease. Molecular Genetics and Metabolism. 108(2). S54–S54. 5 indexed citations

18.

Willcocks, Rebecca J., Sean C. Forbes, Erika Finanger, et al.. (2013). P.13.5 Magnetic resonance imaging and spectroscopy detect changes with age, corticosteroid treatment, and functional progression in DMD. Neuromuscular Disorders. 23(9-10). 810–810. 4 indexed citations

19.

Finanger, Erika, Barry S. Russman, Sean C. Forbes, et al.. (2011). Use of Skeletal Muscle MRI in Diagnosis and Monitoring Disease Progression in Duchenne Muscular Dystrophy. Physical Medicine and Rehabilitation Clinics of North America. 23(1). 1–10. 60 indexed citations

20.

Buono, Russell J., Thomas N. Ferraro, Matthew J. O’Connor, et al.. (2000). Lack of association between temporal lobe epilepsy and a novel polymorphism in the alpha 2 subunit gene (ATP1A2) of the sodium potassium transporting ATPase. American Journal of Medical Genetics. 96(1). 79–83. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact